Immunological treatments for autism.
- 1 January 2000
- journal article
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 30 (5) , 475-479
- https://doi.org/10.1023/a:1005568027292
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 1998
- Pentoxifylline: Brief Review and Rationale for Its Possible Use in the Treatment of AutismJournal of Child Neurology, 1996
- Strong association of the third hypervariable region of HLA-DRβ1 with autismJournal of Neuroimmunology, 1996
- DR-Positive T Cells in Autism: Association with Decreased Plasma Levels of the Complement C4B ProteinNeuropsychobiology, 1995
- Antibodies to Myelin Basic Protein in Children with Autistic BehaviorBrain, Behavior, and Immunity, 1993
- Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral modelPharmacology Biochemistry and Behavior, 1993
- Increased frequency of the null allele at the complement C4b locus in autismClinical and Experimental Immunology, 1991
- Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disordersJournal of Clinical Immunology, 1990
- Elevated Serum Levels of Tumor Necrosis Factor Are Associated With Progressive Encephalopathy in Children With Acquired Immunodeficiency SyndromeArchives of Pediatrics & Adolescent Medicine, 1989
- Effects of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamusNeuropharmacology, 1977